Breakthroughs in medicine led by AI innovation

Breakthroughs in medicine led by AI innovation Significant progress is being made in medical science, driven by artificial intelligence. Developments such as Eli Lilly's retatrutide, a triple agonist, are showing remarkable results in addressing obesity, a condition that has increased dramatically since the Industrial Revolution. New data indicate retatrutide can substantially reduce body fat and associated complications. Recent advances also highlight innovative therapies for cancers previously considered difficult to treat, including melanoma and pancreatic cancer. In addition to their primary effects, GLP-1 agonists are demonstrating noteworthy anti-inflammatory benefits. Experts refer to these developments as part of a "golden age of science," with new possibilities continuously emerging. 📰 @aipost